speb/financial-data huggingface dataset:
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Assets: 143429000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 86224000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Debt: 7694000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 86224000.00
DBV.PA income_statement (quarterly, 2025-06-30) — Total Expenses: 41110000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 57205000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 22188000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 7780000.00
DBV.PA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -41111000.00
DBV.PA income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 648000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 625000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 210169.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1238000.00
DBV.PA balance_sheet (quarterly, 2025-06-30) — Working Capital: 71816000.00
DBV.PA income_statement (quarterly, 2025-09-30) — +Operating Expense: 34277000.00
DBV.PA income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 39816000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 392062000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 3680000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 103207000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -117000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 7691000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 15394000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 69837000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 69837000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 49334000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Cash Financial: 20503000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 130000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -242000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -32434000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -638000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Inventory: -3680000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -994000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 868000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 174000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Payable: -638000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -638000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4270000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Changes In Cash: -32545000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Common Stock: 15394000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 52853000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 130000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Current Assets: 88882000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1001000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Current Debt: 898000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1001000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 49485000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Depreciation: 792000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 792000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2624000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 792000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2624000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — EBIT: -34277000.00
DBV.PA income_statement (quarterly, 2025-09-30) — EBITDA: -31653000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -825000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — End Cash Position: 69837000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 130000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -5681000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -32552000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -5179000.00
DBV.PA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5812000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 21000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 16130000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 52853000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -241000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 130000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6690000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6690000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 130000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Income: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -33164000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -33164000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Interest Income: 1113000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -125000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 1113000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Net PPE: 16130000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -117000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 52832000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -31653000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Normalized Income: -33164000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -32435000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Operating Income: -34277000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 136815508.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 898000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1116000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 502000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Other Gand A: 3262000.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 11000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5462000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1466000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Properties: 16130000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1320000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Other Taxes: -2774000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Payables: 39956000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 39956000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 7412000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 3071000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Pretax Income: -33164000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Receivables: 15974000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 792000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Research And Development: 28615000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -348301000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2550000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5812000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Share Issued: 136975159.00
DBV.PA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 516000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 52853000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 52832000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
DBV.PA income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
DBV.PA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 14654000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Assets: 110495000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 52853000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Debt: 7691000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 52854000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Total Expenses: 34277000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 57641000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 21613000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 8156000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -34277000.00
DBV.PA income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -1113000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 140000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 159651.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 1123000.00
DBV.PA balance_sheet (quarterly, 2025-09-30) — Working Capital: 39397000.00
DBV.PA income_statement (annual, 2025-12-31) — +Operating Expense: 147054000.00
DBV.PA income_statement (quarterly, 2025-12-31) — +Operating Expense: 45048000.00
DBV.PA income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
DBV.PA income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
DBV.PA balance_sheet (annual, 2025-12-31) — Accounts Payable: 40941000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 40941000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -22876000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -22876000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 541251000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 541251000.00
DBV.PA cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 16062000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 2131000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 5189000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 5189000.00
DBV.PA income_statement (annual, 2025-12-31) — Basic Average Shares: 139574259.00
DBV.PA income_statement (annual, 2025-12-31) — Basic EPS: -1.05
DBV.PA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 32456000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 69837000.00
DBV.PA cash_flow (annual, 2025-12-31) — Capital Expenditure: -538000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -379000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6526000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6526000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Capital Stock: 26912000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 26912000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 194167000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 194167000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 194167000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 194167000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Cash Equivalents: 67050000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 67050000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Cash Financial: 127118000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Cash Financial: 127118000.00
DBV.PA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 276182000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 159060000.00
DBV.PA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1369000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -714000.00
DBV.PA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -121183000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -35176000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Account Payable: 15783000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1500000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Inventory: -16062000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2131000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -4699000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 252000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 6521000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 7180000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -203000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -660000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Payable: 15783000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Payable: 1500000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 15783000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1500000.00
DBV.PA cash_flow (annual, 2025-12-31) — Change In Working Capital: 1340000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 6141000.00
DBV.PA cash_flow (annual, 2025-12-31) — Changes In Cash: 153631000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 123171000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Common Stock: 26912000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Common Stock: 26912000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 168770000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 168770000.00
DBV.PA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 276182000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 159060000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Construction In Progress: 1156000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1156000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Current Assets: 212943000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Current Assets: 212943000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1117000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1117000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Current Debt: 1468000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Current Debt: 1468000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2585000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2585000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Current Liabilities: 58025000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 58025000.00
DBV.PA cash_flow (annual, 2025-12-31) — Depreciation: 3194000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Depreciation: 690000.00
DBV.PA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3194000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 690000.00
DBV.PA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 7731000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1454000.00
DBV.PA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3194000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 690000.00
DBV.PA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 7731000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1454000.00
DBV.PA income_statement (annual, 2025-12-31) — Diluted Average Shares: 139574259.00
DBV.PA income_statement (annual, 2025-12-31) — Diluted EPS: -1.05
DBV.PA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -44829000.00
DBV.PA income_statement (annual, 2025-12-31) — EBIT: -147054000.00
DBV.PA income_statement (quarterly, 2025-12-31) — EBIT: -45048000.00
DBV.PA income_statement (annual, 2025-12-31) — EBITDA: -139323000.00
DBV.PA income_statement (quarterly, 2025-12-31) — EBITDA: -43594000.00
DBV.PA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 8080000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 1159000.00
DBV.PA cash_flow (annual, 2025-12-31) — End Cash Position: 194167000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — End Cash Position: 194167000.00
DBV.PA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 276182000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 159060000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -5927000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -5927000.00
DBV.PA cash_flow (annual, 2025-12-31) — Free Cash Flow: -121719000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -35552000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -5430000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -5430000.00
DBV.PA income_statement (annual, 2025-12-31) — General And Administrative Expense: 28277000.00
DBV.PA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 11347000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 22000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 22000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Gross PPE: 37821000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 37821000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Invested Capital: 170238000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 170238000.00
DBV.PA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -1369000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -715000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 5189000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 5189000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Investments And Advances: 5189000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 5189000.00
DBV.PA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 276182000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 159060000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 5409000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 5409000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5409000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5409000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 3528000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 3528000.00
DBV.PA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 276182000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 159060000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Income: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Income: -44829000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -44829000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -44829000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -44829000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -44829000.00
DBV.PA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -146947000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -44829000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -44829000.00
DBV.PA cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -6000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Interest Income: 601000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Interest Income: 597000.00
DBV.PA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 601000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 597000.00
DBV.PA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -831000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -832000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Net PPE: 14945000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Net PPE: 14945000.00
DBV.PA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -532000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -373000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 168748000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 168748000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 620000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 620000.00
DBV.PA income_statement (annual, 2025-12-31) — Normalized EBITDA: -139323000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -43594000.00
DBV.PA income_statement (annual, 2025-12-31) — Normalized Income: -146947000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Normalized Income: -44829000.00
DBV.PA cash_flow (annual, 2025-12-31) — Operating Cash Flow: -121181000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -35173000.00
DBV.PA income_statement (annual, 2025-12-31) — Operating Income: -147054000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Operating Income: -45048000.00
DBV.PA income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
DBV.PA income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
DBV.PA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 235596184.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 235596184.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1468000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1468000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 13907000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 13907000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 497000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 497000.00
DBV.PA income_statement (annual, 2025-12-31) — Other Gand A: 11039000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Other Gand A: 3914000.00
DBV.PA cash_flow (annual, 2025-12-31) — Other Non Cash Items: -217000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -1230000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: -1000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: -1000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1514000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1514000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Properties: 33137000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Properties: 33137000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Other Receivables: 1577000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1577000.00
DBV.PA income_statement (annual, 2025-12-31) — Other Taxes: -5636000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Other Taxes: -645000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Payables: 41533000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Payables: 41533000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 41533000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 41533000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2628000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2628000.00
DBV.PA income_statement (annual, 2025-12-31) — Pretax Income: -146456000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Pretax Income: -44455000.00
DBV.PA cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -6000.00
DBV.PA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -532000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -373000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Receivables: 16148000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Receivables: 16148000.00
DBV.PA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3194000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 690000.00
DBV.PA income_statement (annual, 2025-12-31) — Research And Development: 116682000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Research And Development: 32892000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Retained Earnings: -393129000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -393129000.00
DBV.PA income_statement (annual, 2025-12-31) — Salaries And Wages: 17238000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Salaries And Wages: 7433000.00
DBV.PA income_statement (annual, 2025-12-31) — Selling General And Administration: 28277000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 11347000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Share Issued: 235670864.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Share Issued: 235670864.00
DBV.PA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 5387000.00
DBV.PA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1924000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 168770000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 168770000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 168748000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 168748000.00
DBV.PA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DBV.PA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
DBV.PA income_statement (annual, 2025-12-31) — Tax Provision: 491000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Tax Provision: 374000.00
DBV.PA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
DBV.PA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
DBV.PA balance_sheet (annual, 2025-12-31) — Taxes Receivable: 14571000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 14571000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Assets: 233718000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Assets: 233718000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Capitalization: 168770000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 168770000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Debt: 7994000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Debt: 7994000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 168770000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 168770000.00
DBV.PA income_statement (annual, 2025-12-31) — Total Expenses: 147054000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Total Expenses: 45048000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 64948000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 64948000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 20775000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 20775000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6923000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6923000.00
DBV.PA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -147056000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -45051000.00
DBV.PA income_statement (annual, 2025-12-31) — Total Other Finance Cost: -601000.00
DBV.PA income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -597000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 592000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 592000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 74680.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 74680.00
DBV.PA balance_sheet (annual, 2025-12-31) — Treasury Stock: 834000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 834000.00
DBV.PA balance_sheet (annual, 2025-12-31) — Working Capital: 154918000.00
DBV.PA balance_sheet (quarterly, 2025-12-31) — Working Capital: 154918000.00
DBV.PA income_statement (quarterly, 2026-03-31) — +Operating Expense: 47900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 39500000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 625600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 3000000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 428302850.00
DBV.PA income_statement (quarterly, 2026-03-31) — Basic EPS: -0.11
DBV.PA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 194200000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 6100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 34000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 229200000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 229200000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 186600000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Cash Financial: 42600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 88900000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -200000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -49000000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -500000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Inventory: -3000000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -4700000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Payable: -500000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -500000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -7600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 39500000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Common Stock: 34000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 208000000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 89100000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -200000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Current Assets: 246700000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 51800000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Depreciation: 900000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2000000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2000000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 428302850.00
DBV.PA income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.11
DBV.PA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -47600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — EBIT: -47900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — EBITDA: -45900000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -4500000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — End Cash Position: 229200000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 88900000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -10300000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -49500000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -9900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 13400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 14100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 208000000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -300000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 89100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5100000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 88900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Income: -47600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -47600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -47600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -47600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -47600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -47600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -47600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Interest Income: 500000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 500000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Net PPE: 14100000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 207900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -45900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Normalized Income: -47600000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -49100000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Operating Income: -47900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 295914379.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 400000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Other Gand A: 7800000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 5500000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1600000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Other Properties: 14100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1000000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Other Taxes: -900000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Payables: 40100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 40100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9700000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2400000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Pretax Income: -47400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Receivables: 15100000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 900000.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -200000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Research And Development: 33400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -440700000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5600000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 13400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Share Issued: 296042447.00
DBV.PA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2300000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 208000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 207900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
DBV.PA income_statement (quarterly, 2026-03-31) — Tax Provision: 200000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
DBV.PA balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 14100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Assets: 266400000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 208000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Debt: 6100000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 207900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Total Expenses: 47900000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 58500000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 19700000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6700000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -47900000.00
DBV.PA income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -500000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 600000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 128068.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1000000.00
DBV.PA balance_sheet (quarterly, 2026-03-31) — Working Capital: 194900000.00
DBVT balance_sheet (annual, 2021-12-31) — Accounts Receivable: 0.00
DBVT balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 2665000.00
DBVT income_statement (annual, 2021-12-31) — Basic Average Shares: 10989775.00
DBVT income_statement (annual, 2021-12-31) — Basic EPS: -8.90
DBVT balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 3958000.00
DBVT cash_flow (annual, 2021-12-31) — Change In Receivables: 2150000.00
DBVT cash_flow (annual, 2021-12-31) — Changes In Account Receivables: 2150000.00
DBVT balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 4146000.00
DBVT balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 4146000.00
DBVT income_statement (annual, 2021-12-31) — Diluted Average Shares: 10989775.00
DBVT income_statement (annual, 2021-12-31) — Diluted EPS: -8.90
DBVT balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 2665000.00
DBVT balance_sheet (annual, 2021-12-31) — Investments And Advances: 2665000.00
DBVT cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -119000.00
DBVT cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -704000.00
DBVT balance_sheet (annual, 2021-12-31) — Non Current Accounts Receivable: 199000.00
DBVT balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 2665000.00
DBVT cash_flow (annual, 2021-12-31) — Operating Gains Losses: 184000.00
DBVT balance_sheet (annual, 2021-12-31) — Other Current Assets: 1000.00
DBVT income_statement (annual, 2021-12-31) — Other Income Expense: 920000.00
DBVT income_statement (annual, 2021-12-31) — Other Operating Expenses: 1797000.00
DBVT cash_flow (annual, 2021-12-31) — Pension And Employee Benefit Expense: 184000.00
DBVT balance_sheet (annual, 2021-12-31) — Properties: 0.00
DBVT cash_flow (annual, 2021-12-31) — Purchase Of Investment: -119000.00
DBVT income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: -920000.00
DBVT cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
DBVT cash_flow (annual, 2021-12-31) — Sale Of PPE: 604000.00
DBVT income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 4387000.00
DBVT income_statement (annual, 2021-12-31) — Special Income Charges: 920000.00
DBVT income_statement (annual, 2021-12-31) — Total Unusual Items: 920000.00
DBVT income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 920000.00
DBVT income_statement (annual, 2022-12-31) — +Operating Expense: 96631000.00
DBVT income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
DBVT balance_sheet (annual, 2022-12-31) — Accounts Payable: 14473000.00
DBVT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 0.00
DBVT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -14788000.00
DBVT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 458221000.00
DBVT balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1773000.00
DBVT income_statement (annual, 2022-12-31) — Basic Average Shares: 15532258.00
DBVT income_statement (annual, 2022-12-31) — Basic EPS: -6.20
DBVT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 77301000.00
DBVT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 3214000.00
DBVT cash_flow (annual, 2022-12-31) — Capital Expenditure: -754000.00
DBVT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3021000.00
DBVT balance_sheet (annual, 2022-12-31) — Capital Stock: 10720000.00
DBVT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 209194000.00
DBVT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 209194000.00
DBVT balance_sheet (annual, 2022-12-31) — Cash Equivalents: 179090000.00
DBVT balance_sheet (annual, 2022-12-31) — Cash Financial: 30104000.00
DBVT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 194120000.00
DBVT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -99000.00
DBVT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -55668000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Account Payable: 3456000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Inventory: 0.00
DBVT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 20961000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 152000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2249000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Payable: 3456000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 3456000.00
DBVT cash_flow (annual, 2022-12-31) — Change In Receivables: 0.00
DBVT cash_flow (annual, 2022-12-31) — Change In Working Capital: 22320000.00
DBVT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 0.00
DBVT cash_flow (annual, 2022-12-31) — Changes In Cash: 138354000.00
DBVT balance_sheet (annual, 2022-12-31) — Common Stock: 10720000.00
DBVT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 194454000.00
DBVT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 194594000.00
DBVT balance_sheet (annual, 2022-12-31) — Construction In Progress: 4468000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Assets: 223074000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1894000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Debt: 1131000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3025000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 2137000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 2137000.00
DBVT balance_sheet (annual, 2022-12-31) — Current Liabilities: 29521000.00
DBVT cash_flow (annual, 2022-12-31) — Depreciation: 13162000.00
DBVT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 13162000.00
DBVT income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 8369000.00
DBVT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 13162000.00
DBVT income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 8369000.00
DBVT income_statement (annual, 2022-12-31) — Diluted Average Shares: 15532258.00